Kidney disease drug study: will empagliflozin change mineral balance?
Knowledge-focused
Recruiting now
This study looks at how Empagliflozin, a diabetes drug, affects calcium, phosphate, and magnesium levels in people with autosomal dominant polycystic kidney disease (ADPKD). About 40 adults will take either the drug or a placebo for 2 weeks, then switch. The goal is to understand…
Phase: PHASE2 • Sponsor: Cantonal Hospital Graubuenden • Aim: Knowledge-focused
Last updated May 17, 2026 06:47 UTC